Changeflow GovPing Banking & Finance BaFin Imposes Administrative Fine on aap Implan...
Urgent Enforcement Added Final

BaFin Imposes Administrative Fine on aap Implantate AG

Favicon for www.bafin.de BaFin News & Warnings
Filed March 3rd, 2026
Detected March 19th, 2026
Email

Summary

BaFin has imposed an administrative fine of 158,000 euros on aap Implantate AG for violating the German Securities Trading Act. The company failed to publish a required announcement regarding the availability of its 2024 half-yearly financial report.

What changed

BaFin announced on March 3, 2026, that it has imposed an administrative fine of 158,000 euros on aap Implantate AG. The fine was levied because the company contravened Section 40c of the German Securities Trading Act (WpHG) by failing to publish a timely announcement about the date and website where its 2024 half-yearly financial report would be made publicly available. This announcement is a mandatory requirement for companies whose securities are traded on a German organized market, and it must be published before the report's release to ensure simultaneous access for all stakeholders.

This enforcement action highlights the critical importance of adhering to financial disclosure and announcement requirements. Publicly traded companies must ensure they have robust processes in place to meet these obligations, including timely publication of financial reports and advance notice of their availability. Failure to comply can result in significant administrative fines, with potential penalties reaching up to 10 million euros or 5% of total revenue. Compliance officers should review their procedures for financial report dissemination and announcement publication to prevent similar violations.

What to do next

  1. Review procedures for timely publication of financial report availability announcements.
  2. Ensure compliance with Section 40c of the German Securities Trading Act (WpHG) for all future financial reports.

Penalties

Administrative fine amounting to 158,000 euros. Maximum potential fine is 10 million euros or up to 5% of total revenue.

Source document (simplified)

Erscheinung: 18.03.2026 | Topic Measures aap Implantate AG: BaFin imposes administrative fine

On 3 March 2026, BaFin imposed an administrative fine amounting to 158,000 euros on aap Implantate AG. The company had contravened an obligation under the German Securities Trading Act (Wertpapierhandelsgesetz – WpHG). aap Implantate AG failed to publish an announcement about the date from which and the website where its 2024 half-yearly financial report was made publicly available.

Companies must publish an announcement stating when and where they will publish their financial reports on the internet. The purpose of the announcement is to enable all stakeholders to familiarise themselves with the financial reports at the same time.

Background information:

Financial reports contain, among other details, information on the overall financial situation of a company (net assets, financial position and results of operations) and describe the company’s expected development as well as the significant opportunities and risks. This information is important for investors because it allows them to make informed investment decisions. Companies such as aap Implantate AG that are domiciled in Germany and that issue securities that are traded on an organised market in Germany must publish an announcement stating when and where they will make their half-yearly financial reports  publicly available on the internet in addition to its disclosure in the Company Register (Unternehmensregister). Such announcements must be published no later than three months after the end of each reporting period and before the date on which the half-yearly financial report is made publicly available for the first time.

Failure to publish such an announcement constitutes a contravention of the WpHG. BaFin may impose administrative fines for failure to comply with this requirement. The maximum amount for this fine is 10 million euros or up to 5% of total revenue.

Switch to announcement

Did you find this article helpful?

We appreciate your feedback Your feedback helps us to continuously improve the website and to keep it up to date. If you have any questions and would like us to contact you, please use our contact form. Please send any disclosures about actual or suspected violations of supervisory provisions to our contact point for whistleblowers.

We appreciate your feedback helpful less helpful Comment (max. 1000 characters): * Mandatory field

Navigation

Named provisions

Half-yearly financial report

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
BaFin
Filed
March 3rd, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
40c_neu_124_WpHG

Who this affects

Applies to
Public companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Financial Reporting
Threshold
Companies domiciled in Germany and issuing securities traded on an organised market in Germany.
Geographic scope
Germany DE

Taxonomy

Primary area
Securities
Operational domain
Compliance
Topics
Financial Reporting Market Abuse

Get Banking & Finance alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when BaFin News & Warnings publishes new changes.

Free. Unsubscribe anytime.